These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 23837865

  • 1. Sensitivity of PEGylated interferon detection by anti-polyethylene glycol (PEG) antibodies depends on PEG length.
    Cheng TC, Chuang KH, Chen M, Wang HE, Tzou SC, Su YC, Chuang CH, Kao CH, Chen BM, Chang LS, Roffler SR, Cheng TL.
    Bioconjug Chem; 2013 Aug 21; 24(8):1408-13. PubMed ID: 23837865
    [Abstract] [Full Text] [Related]

  • 2. Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies.
    Su YC, Chen BM, Chuang KH, Cheng TL, Roffler SR.
    Bioconjug Chem; 2010 Jul 21; 21(7):1264-70. PubMed ID: 20536171
    [Abstract] [Full Text] [Related]

  • 3. Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA.
    Chuang KH, Tzou SC, Cheng TC, Kao CH, Tseng WL, Shiea J, Liao KW, Wang YM, Chang YC, Huang BJ, Wu CJ, Chu PY, Roffler SR, Cheng TL.
    Anal Chem; 2010 Mar 15; 82(6):2355-62. PubMed ID: 20178318
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles.
    Cheng TL, Cheng CM, Chen BM, Tsao DA, Chuang KH, Hsiao SW, Lin YH, Roffler SR.
    Bioconjug Chem; 2005 Mar 15; 16(5):1225-31. PubMed ID: 16173802
    [Abstract] [Full Text] [Related]

  • 5. Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles.
    Hsieh YC, Cheng TC, Wang HE, Li JJ, Lin WW, Huang CC, Chuang CH, Wang YT, Wang JY, Roffler SR, Chuang KH, Cheng TL.
    Sci Rep; 2016 Dec 19; 6():39119. PubMed ID: 27991598
    [Abstract] [Full Text] [Related]

  • 6. A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers.
    Liu Y, Reidler H, Pan J, Milunic D, Qin D, Chen D, Vallejo YR, Yin R.
    J Pharmacol Toxicol Methods; 2011 Dec 19; 64(3):238-45. PubMed ID: 21827863
    [Abstract] [Full Text] [Related]

  • 7. Optimization of an Anti-poly(ethylene glycol) (anti-PEG) Cell-Based Capture System To Quantify PEG and PEGylated Molecules.
    Lin WW, Hsieh YC, Cheng YA, Chuang KH, Huang CC, Chuang CH, Chen IJ, Cheng KW, Lu YC, Cheng TC, Wang YT, Roffler SR, Cheng TL.
    Anal Chem; 2016 Dec 20; 88(24):12371-12379. PubMed ID: 28193011
    [Abstract] [Full Text] [Related]

  • 8. Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules.
    Lin WW, Cheng YA, Kao CH, Roffler SR, Lee YC, Chen BM, Hsieh YC, Chen IJ, Huang BC, Wang YT, Tung YC, Huang MY, Chen FM, Cheng TL.
    Anal Chem; 2017 Jun 06; 89(11):6082-6090. PubMed ID: 28485140
    [Abstract] [Full Text] [Related]

  • 9. Analytical measurement of PEGylated molecules.
    Cheng TL, Chuang KH, Chen BM, Roffler SR.
    Bioconjug Chem; 2012 May 16; 23(5):881-99. PubMed ID: 22242549
    [Abstract] [Full Text] [Related]

  • 10. Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.
    Pepinsky RB, LePage DJ, Gill A, Chakraborty A, Vaidyanathan S, Green M, Baker DP, Whalley E, Hochman PS, Martin P.
    J Pharmacol Exp Ther; 2001 Jun 16; 297(3):1059-66. PubMed ID: 11356929
    [Abstract] [Full Text] [Related]

  • 11. PEGylated recombinant human interferon-ω as a long-acting antiviral agent: structure, antiviral activity and pharmacokinetics.
    Yu W, Yu C, Wu L, Fang T, Qiu R, Zhang J, Yu T, Fu L, Chen W, Hu T.
    Antiviral Res; 2014 Aug 16; 108():142-7. PubMed ID: 24936771
    [Abstract] [Full Text] [Related]

  • 12. Antibodies against polyethylene glycol in human blood: A literature review.
    Hong L, Wang Z, Wei X, Shi J, Li C.
    J Pharmacol Toxicol Methods; 2020 Aug 16; 102():106678. PubMed ID: 31981619
    [Abstract] [Full Text] [Related]

  • 13. Quantitative determination of pegylated consensus interferon in rhesus monkey serum using a competitive enzyme-linked immunosorbent assay.
    Cao J, Du Y, Tian H, Gao XD, Yao WB.
    Immunopharmacol Immunotoxicol; 2009 Aug 16; 31(4):543-9. PubMed ID: 19874220
    [Abstract] [Full Text] [Related]

  • 14. Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins.
    Saifer MG, Williams LD, Sobczyk MA, Michaels SJ, Sherman MR.
    Mol Immunol; 2014 Feb 16; 57(2):236-46. PubMed ID: 24200843
    [Abstract] [Full Text] [Related]

  • 15. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies.
    Wang SJ, Wu ST, Gokemeijer J, Fura A, Krishna M, Morin P, Chen G, Price K, Wang-Iverson D, Olah T, Weiner R, Tymiak A, Jemal M.
    Anal Bioanal Chem; 2012 Jan 16; 402(3):1229-39. PubMed ID: 22130720
    [Abstract] [Full Text] [Related]

  • 16. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.
    Yang Z, Wang J, Lu Q, Xu J, Kobayashi Y, Takakura T, Takimoto A, Yoshioka T, Lian C, Chen C, Zhang D, Zhang Y, Li S, Sun X, Tan Y, Yagi S, Frenkel EP, Hoffman RM.
    Cancer Res; 2004 Sep 15; 64(18):6673-8. PubMed ID: 15374983
    [Abstract] [Full Text] [Related]

  • 17. [Development and evaluation of a quantitative double antibodies sandwich ELISA assay for rIFN-alpha1b].
    Wu MY, Ai YP, Cao Y, Wu S, Niu XX, Cheng YQ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec 15; 26(6):489-91. PubMed ID: 23627039
    [Abstract] [Full Text] [Related]

  • 18. Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice.
    Elsadek NE, Hondo E, Shimizu T, Takata H, Abu Lila AS, Emam SE, Ando H, Ishima Y, Ishida T.
    Mol Pharm; 2020 Aug 03; 17(8):2964-2970. PubMed ID: 32519877
    [Abstract] [Full Text] [Related]

  • 19. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S, Choi JW, Godwin A, Teo I, Laborde CM, Heidelberger S, Zloh M, Shaunak S, Brocchini S.
    Bioconjug Chem; 2007 Aug 03; 18(1):61-76. PubMed ID: 17226958
    [Abstract] [Full Text] [Related]

  • 20. Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.
    Zhang P, Sun F, Liu S, Jiang S.
    J Control Release; 2016 Dec 28; 244(Pt B):184-193. PubMed ID: 27369864
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.